Evaluation of the Frequency of Limitation of Activity in Patients With Persistent Asthma (ASMAVIE)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
To describe the frequency of limitations of activities in patients with persistent asthma depending on gender and age-group. [ Time Frame: Last 3 months / once ]
To describe, depending on gender and age-group, the nature of the activities limited, the degree of limitation and the impact on the patient's daily life. [ Time Frame: Once during only visit ]
Secondary Outcome Measures
To describe the nature of the activities limited, the degree of limitation and the impact on the patient's daily life according to the level of asthma control [ Time Frame: Once during only visit ]
To describe, depending on gender and age-group, the activities that need to be specifically investigated in routine clinical practice due to their greater impact on the patient's quality of life, and which could indicate poorly controlled asthma [ Time Frame: Once during only visit ]
To describe the main characteristics and initial management for all patients of the survey [ Time Frame: Once during only visit ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
First 3 consecutive patients with persistent asthma seen by general practitioner receiving long-term maintenance treatment with inhaled steroids
persistent asthma receiving long-term maintenance treatment with inhaled steroids (alone or in combination with other drugs)